Is taking 20 mg of Adderall (mixed amphetamine salts) three times a day appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adderall 20mg Three Times Daily: Exceeds Recommended Maximum Dosing

A total daily dose of 60mg of Adderall (20mg three times daily) is at the absolute upper limit of FDA-approved dosing and should only rarely be used, with most patients achieving optimal symptom control at lower doses. 1

FDA-Approved Maximum Dosing

The FDA label for Adderall explicitly states that the maximum total daily dose is 40mg for amphetamines in children and adolescents 1. For adults, while the label mentions doses up to 60mg per day for narcolepsy, this represents an absolute ceiling rather than a target dose 1.

Guideline-Based Dosing Recommendations

Starting and Titration Strategy

  • Initial dose: 2.5-5mg once or twice daily 2
  • Titration increments: Increase by 2.5-5mg weekly until optimal response 2
  • Typical effective range: Most patients respond to total daily doses of 20-40mg 2

Expert Consensus on Upper Limits

The 2002 practice parameter from the Journal of the American Academy of Child and Adolescent Psychiatry notes that "experts often limit the upper range to a total daily dose of 40mg of amphetamine" 2. The guideline explicitly warns: "If the top recommended dose does not help, more is not necessarily better. A change in drug or environmental or psychosocial intervention may be required." 2

Clinical Decision Algorithm

When encountering a patient on 60mg total daily dose:

  1. Verify symptom control: Use standardized ADHD rating scales from multiple sources (patient, family, work/school) 3, 2

  2. Assess for tolerance: Document whether this high dose is truly necessary or represents dose escalation without corresponding benefit 2

  3. Monitor for adverse effects systematically:

    • Blood pressure and pulse (quarterly minimum) 2
    • Weight loss and appetite suppression 2
    • Sleep disturbance, agitation, or cardiovascular symptoms 2
    • Signs of misuse or diversion
  4. Consider dose reduction trial: If patient has been stable, attempt gradual reduction to 30-40mg total daily to determine minimum effective dose 3

  5. Evaluate alternative strategies if inadequate response:

    • Switch to different stimulant formulation (long-acting preparations may provide better coverage) 2
    • Add behavioral interventions or contingency management 3
    • Assess and treat comorbid conditions 3
    • Consider non-stimulant augmentation

Duration of Action Considerations

Research demonstrates that twice-daily dosing of immediate-release Adderall provides superior afternoon symptom control compared to once-daily dosing 4. However, three-times-daily dosing at 20mg per dose is excessive. A more rational approach would be:

  • Use extended-release formulations (which provide 12-hour coverage) 5, 6
  • If using immediate-release: 10-15mg morning, 10-15mg midday, with optional smaller afternoon dose (5-10mg) if needed 2

Critical Safety Concerns at This Dose

At 60mg total daily:

  • Cardiovascular risk: Increased blood pressure and heart rate become more pronounced 2
  • Psychiatric effects: Higher risk of agitation, anxiety, and mood changes 2
  • Appetite suppression: Significant weight loss becomes more likely 2
  • Sleep disruption: Evening doses substantially interfere with sleep onset 2
  • Tolerance and dependence: Higher doses may indicate developing tolerance 2

Documentation Requirements

If continuing 60mg daily, medical records must clearly document:

  • Failure of lower doses to control symptoms despite adequate trials 2
  • Absence of prohibitive side effects at current dose 2
  • Objective evidence of benefit using validated rating scales 2
  • Regular monitoring of vital signs, weight, and mental status 2

Recommended Action

For most patients, reduce total daily dose to 30-40mg distributed across the day, or transition to long-acting formulation at equivalent dosing. The 2019 Pediatrics guideline emphasizes that "the PCC should titrate doses of medication for ADHD to achieve maximum benefit with tolerable side effects" 3, not simply escalate to maximum doses. The goal is the minimum effective dose that normalizes function, not the maximum tolerated dose.

Related Questions

Can I start a 40-year-old patient on mixed amphetamine salts (Adderall) 10 mg twice daily?
Is it safe to restart mixed amphetamine salts in a patient who used them a few years ago, assuming no prior significant side effects or cardiovascular issues?
For a patient currently taking Adderall (mixed amphetamine salts) 20 mg twice daily, would switching to 30 mg extended‑release in the morning and 20 mg immediate‑release in the afternoon be a safer regimen?
For a patient taking 30 mg of immediate‑release Adderall (mixed amphetamine salts) who still experiences evening crashes, what medication can be used to prevent these crashes?
What is the effect of Adderall (mixed amphetamine salts) on appetite and how can appetite suppression be managed?
As a nurse, what actions should I take when a patient’s point‑of‑care blood glucose reading is high?
Can tetracycline be substituted with doxycycline in Helicobacter pylori quadruple therapy?
Can administering sodium bicarbonate in total doses of 50 to 150 milliequivalents precipitate hypokalemia?
In home health care, how should I manage a patient with a high point‑of‑care glucose reading when I cannot obtain a rapid laboratory blood draw?
What will be the size of a 48‑gram prostate due to benign prostatic hyperplasia after one year without treatment?
Is a patient with an abdominal aortic aneurysm measuring 3.3 × 3.2 × 3.1 cm on CT aortogram considered low‑risk or high‑risk for undergoing esophagogastroduodenoscopy (EGD) and colonoscopy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.